Cetera Investment Advisers Xeris Biopharma Holdings, Inc. Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 46,332 shares of XERS stock, worth $339,613. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,332
Previous 44,597
3.89%
Holding current value
$339,613
Previous $244,000
11.48%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
220Shares Held
89.9MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$75.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$72 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$28.1 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$27.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$26.8 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $997M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...